Sustained innate interferon is an essential inducer of tertiary lymphoid structures
European Journal of Immunology · 2024
DOI: 10.1002/eji.202451207 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Anna Laura Calvanese und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Tertiary Lymphoid Structures, Interferon Type I, Immunity, Innate. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hartmann Müller-Stiftung für Medizinische Forschung, Zurich Cancer League, Universität Zürich.
Abstract (Originalsprache)
Tertiary lymphoid structures (TLS) resemble follicles of secondary lymphoid organs and develop in nonlymphoid tissues during inflammation and cancer. Which cell types and signals drive the development of TLS is largely unknown. To investigate early events of TLS development in the lungs, we repeatedly instilled p(I:C) plus ovalbumin (Ova) intranasally. This induced TLS ranging from lymphocytic aggregates to organized and functional structures containing germinal centers. We found that TLS development is independent of FAP + fibroblasts, alveolar macrophages, or CCL19 but crucially depends on type I interferon (IFN‐I). Mechanistically, IFN‐I initiates two synergistic pathways that culminate in the development of TLS. On the one hand, IFN‐I induces lymphotoxin (LT)α in lymphoid cells, which stimulate stromal cells to produce the B‐cell‐attracting chemokine CXCL13 through LTβR‐signaling. On the other hand, IFN‐I is sensed by stromal cells that produce the T‐cell‐attracting chemokines CXCL9, CXCL10 as well as CCL19 and CCL21 independently of LTβR. Consequently, B‐cell aggregates develop within a week, whereas follicular dendritic cells and germinal centers appear after 3 weeks. Thus, sustained production of IFN‐I together with an antigen is essential for the induction of functional TLS in the lungs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
- Institute of Virology, Medical Center University of Freiburg, Freiburg im Breisgau, Germany.
- Institute of Physiology, University of Zurich, Zurich, Switzerland.
- Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany.
- M3 Research Institute, Eberhard Karls University Tübingen, Tübingen, Germany.
- Institute of Immunobiology, Medical Research Center, Kantonsspital St. Gallen, St. Gallen, Switzerland.
ORCID-Profile: Anna Laura Calvanese, Daniel Schnepf, Marc Nater, Christoph Schneider, Karina Silina, Maries van den Broek
Förderung
- Hartmann Müller-Stiftung für Medizinische Forschung
- Zurich Cancer League
- Universität Zürich
- Lungenliga Schweiz
- Swiss National Science Foundation
- Worldwide Cancer Research
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Zitieren
APA
Calvanese, A. L., Cecconi, V., Stäheli, S., Schnepf, D., Nater, M., Pereira, P., Gschwend, J., Heikenwälder, M., Schneider, C., Ludewig, B., Silina, K., & van den Broek, M. (2024). Sustained innate interferon is an essential inducer of tertiary lymphoid structures. European Journal of Immunology. https://doi.org/10.1002/eji.202451207
Vancouver
Calvanese AL, Cecconi V, Stäheli S, Schnepf D, Nater M, Pereira P, et al. Sustained innate interferon is an essential inducer of tertiary lymphoid structures. European Journal of Immunology. 2024. doi:10.1002/eji.202451207
BibTeX
@article{Calvanese2024,
author = {Calvanese, Anna Laura and Cecconi, Virginia and Stäheli, Severin and Schnepf, Daniel and Nater, Marc and Pereira, Paulo and Gschwend, Julia and Heikenwälder, Mathias and Schneider, Christoph and Ludewig, Burkhard and Silina, Karina and van den Broek, Maries},
title = {Sustained innate interferon is an essential inducer of tertiary lymphoid structures},
journal = {European Journal of Immunology},
year = {2024},
doi = {10.1002/eji.202451207}
}
EUVIMED